BDBM102145 US8530648, 42

SMILES: Cc1cccc(CN2CCCC3(CCN(CC3)c3cnc4ccccc4n3)C2=O)c1

InChI Key: InChIKey=JVQBNXYNNZDXQF-UHFFFAOYSA-N

Data: 2 KI  2 Kd

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 102145   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Orexin receptor type 2 (Homo sapiens (Human))	BDBM102145 (US8530648, 42) Show SMILES Cc1cccc(CN2CCCC3(CCN(CC3)c3cnc4ccccc4n3)C2=O)c1 Show InChI InChI=1S/C25H28N4O/c1-19-6-4-7-20(16-19)18-29-13-5-10-25(24(29)30)11-14-28(15-12-25)23-17-26-21-8-2-3-9-22(21)27-23/h2-4,6-9,16-17H,5,10-15,18H2,1H3	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	155	n/a	n/a	n/a	n/a	n/a	n/a	7.4	n/a
Novartis AG US Patent					Assay Description FLIPR assay using orexin receptor.				US Patent US8530648 (2013) BindingDB Entry DOI: 10.7270/Q2SB44DR
					More data for this Ligand-Target Pair
Orexin receptor type 1 (Homo sapiens (Human))	BDBM102145 (US8530648, 42) Show SMILES Cc1cccc(CN2CCCC3(CCN(CC3)c3cnc4ccccc4n3)C2=O)c1 Show InChI InChI=1S/C25H28N4O/c1-19-6-4-7-20(16-19)18-29-13-5-10-25(24(29)30)11-14-28(15-12-25)23-17-26-21-8-2-3-9-22(21)27-23/h2-4,6-9,16-17H,5,10-15,18H2,1H3	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	1.38E+3	n/a	n/a	n/a	n/a	n/a	n/a	7.4	n/a
Novartis AG US Patent					Assay Description FLIPR assay using orexin receptor.				US Patent US8530648 (2013) BindingDB Entry DOI: 10.7270/Q2SB44DR
					More data for this Ligand-Target Pair
Orexin receptor type 2 (Homo sapiens (Human))	BDBM102145 (US8530648, 42) Show SMILES Cc1cccc(CN2CCCC3(CCN(CC3)c3cnc4ccccc4n3)C2=O)c1 Show InChI InChI=1S/C25H28N4O/c1-19-6-4-7-20(16-19)18-29-13-5-10-25(24(29)30)11-14-28(15-12-25)23-17-26-21-8-2-3-9-22(21)27-23/h2-4,6-9,16-17H,5,10-15,18H2,1H3	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	n/a	288	n/a	n/a	n/a	7.5	n/a
Novartis AG US Patent					Assay Description Radioligand binding assay using orexin receptor.				US Patent US8530648 (2013) BindingDB Entry DOI: 10.7270/Q2SB44DR
					More data for this Ligand-Target Pair
Orexin receptor type 1 (Homo sapiens (Human))	BDBM102145 (US8530648, 42) Show SMILES Cc1cccc(CN2CCCC3(CCN(CC3)c3cnc4ccccc4n3)C2=O)c1 Show InChI InChI=1S/C25H28N4O/c1-19-6-4-7-20(16-19)18-29-13-5-10-25(24(29)30)11-14-28(15-12-25)23-17-26-21-8-2-3-9-22(21)27-23/h2-4,6-9,16-17H,5,10-15,18H2,1H3	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	n/a	1.40E+3	n/a	n/a	n/a	7.5	n/a
Novartis AG US Patent					Assay Description Radioligand binding assay using orexin receptor.				US Patent US8530648 (2013) BindingDB Entry DOI: 10.7270/Q2SB44DR
					More data for this Ligand-Target Pair